Latest Insider Transactions at Merck & Co., Inc. (MRK)
This section provides a real-time view of insider transactions for Merck & Co., Inc. (MRK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Merck & Co., Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Merck & Co., Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 04
2022
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
447
-2.99%
|
$38,889
$87.1 P/Share
|
|
May 04
2022
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
907
+5.72%
|
$78,909
$87.1 P/Share
|
|
May 03
2022
|
Arpa Garay SVP Human Health Global Mktg. |
SELL
Payment of exercise price or tax liability
|
Direct |
221
-13.14%
|
$19,227
$87.65 P/Share
|
|
May 03
2022
|
Arpa Garay SVP Human Health Global Mktg. |
BUY
Exercise of conversion of derivative security
|
Direct |
773
+31.49%
|
$67,251
$87.65 P/Share
|
|
May 03
2022
|
Michael A Klobuchar EVP - Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-2.5%
|
$33,147
$87.65 P/Share
|
|
May 03
2022
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
773
+4.82%
|
$67,251
$87.65 P/Share
|
|
May 03
2022
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-2.64%
|
$33,147
$87.65 P/Share
|
|
May 03
2022
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
773
+5.08%
|
$67,251
$87.65 P/Share
|
|
May 03
2022
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
309
-0.76%
|
$26,883
$87.65 P/Share
|
|
May 03
2022
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
902
+2.16%
|
$78,474
$87.65 P/Share
|
|
May 03
2022
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
147
-1.56%
|
$12,789
$87.65 P/Share
|
|
May 03
2022
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
427
+4.34%
|
$37,149
$87.65 P/Share
|
|
May 03
2022
|
Dean Y Li Executive VP & President, MRL |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-2.26%
|
$33,147
$87.65 P/Share
|
|
May 03
2022
|
Dean Y Li Executive VP & President, MRL |
BUY
Exercise of conversion of derivative security
|
Direct |
773
+4.39%
|
$67,251
$87.65 P/Share
|
|
May 03
2022
|
Caroline Litchfield EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
373
-1.34%
|
$32,451
$87.65 P/Share
|
|
May 03
2022
|
Caroline Litchfield EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
773
+2.71%
|
$67,251
$87.65 P/Share
|
|
May 03
2022
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
155
-4.72%
|
$13,485
$87.65 P/Share
|
|
May 03
2022
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
452
+12.1%
|
$39,324
$87.65 P/Share
|
|
May 01
2022
|
Arpa Garay SVP Human Health Global Mktg. |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-21.37%
|
$21,736
$88.69 P/Share
|
|
May 01
2022
|
Arpa Garay SVP Human Health Global Mktg. |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+42.83%
|
$76,208
$88.69 P/Share
|
|
May 01
2022
|
Michael A Klobuchar EVP - Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-2.86%
|
$37,576
$88.69 P/Share
|
|
May 01
2022
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+5.48%
|
$76,208
$88.69 P/Share
|
|
May 01
2022
|
Johannes Jacobus Oosthuizen President, U.S. Market |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-3.03%
|
$37,576
$88.69 P/Share
|
|
May 01
2022
|
Johannes Jacobus Oosthuizen President, U.S. Market |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+5.79%
|
$76,208
$88.69 P/Share
|
|
May 01
2022
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-0.79%
|
$27,984
$88.69 P/Share
|
|
May 01
2022
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
928
+2.26%
|
$81,664
$88.69 P/Share
|
|
May 01
2022
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
198
-2.16%
|
$17,424
$88.69 P/Share
|
|
May 01
2022
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
577
+5.91%
|
$50,776
$88.69 P/Share
|
|
May 01
2022
|
Dean Y Li Executive VP & President, MRL |
SELL
Payment of exercise price or tax liability
|
Direct |
523
-3.15%
|
$46,024
$88.69 P/Share
|
|
May 01
2022
|
Dean Y Li Executive VP & President, MRL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,061
+6.01%
|
$93,368
$88.69 P/Share
|
|
May 01
2022
|
Caroline Litchfield EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-1.56%
|
$37,576
$88.69 P/Share
|
|
May 01
2022
|
Caroline Litchfield EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+3.06%
|
$76,208
$88.69 P/Share
|
|
May 01
2022
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-7.21%
|
$19,360
$88.69 P/Share
|
|
May 01
2022
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
640
+17.33%
|
$56,320
$88.69 P/Share
|
|
Feb 24
2022
|
Robert M Davis Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
29,896
+10.77%
|
$2,182,408
$73.51 P/Share
|
|
Feb 24
2022
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Grant, award, or other acquisition
|
Direct |
19,836
+14.93%
|
$1,448,028
$73.51 P/Share
|
|
Feb 24
2022
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct |
15,966
+10.65%
|
$1,165,518
$73.51 P/Share
|
|
Feb 24
2022
|
Kenneth C Frazier Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
119,488
+14.47%
|
$8,722,624
$73.51 P/Share
|
|
Feb 24
2022
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,550
+16.39%
|
$697,150
$73.51 P/Share
|
|
Feb 24
2022
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Grant, award, or other acquisition
|
Direct |
3,478
+8.13%
|
$253,894
$73.51 P/Share
|
|
Feb 24
2022
|
Michael A Klobuchar EVP - Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,994
+17.56%
|
$218,562
$73.51 P/Share
|
|
Feb 24
2022
|
Dean Y Li Executive VP & President, MRL |
BUY
Grant, award, or other acquisition
|
Direct |
3,023
+16.35%
|
$220,679
$73.51 P/Share
|
|
Feb 24
2022
|
Caroline Litchfield EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,429
+8.38%
|
$177,317
$73.51 P/Share
|
|
Feb 24
2022
|
Steven Mizell EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,571
+26.63%
|
$1,063,683
$73.51 P/Share
|
|
Feb 24
2022
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,660
+16.17%
|
$121,180
$73.51 P/Share
|
|
Feb 24
2022
|
Jennifer Zachary EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
18,420
+25.64%
|
$1,344,660
$73.51 P/Share
|
|
Feb 10
2022
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-6.43%
|
$36,252
$76.53 P/Share
|
|
Feb 10
2022
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,202
+13.94%
|
$91,352
$76.53 P/Share
|
|
Nov 09
2021
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
663,881
-27.76%
|
$54,438,242
$82.73 P/Share
|
|
Nov 09
2021
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
663,881
+34.68%
|
-
|